CONFIRMED SPEAKERS INCLUDE:

Dr. Joerg Dreyhsig

VP Associate General Counsel IP
Fresenius Medical Care AG & Co. KGaA

Karine Crepin

Global Head of Biologics Patents
Sanofi Global IP Department

Emilie Frugier

Patent Manager
NBE Therapeutics AG

Dr. Oliver Werner

Head of SPC Working Group
German Patent Trade Mark Office

Stella Fletcher

Head of IP
BIAL – Portela

Paul Inman

Partner
Gowling WLG

Chair’s Opening Speech

October 17, 2018 9:00 am

Fredrik Fredh

European Patent Attorney
Novartis Pharma AG

Dr Philipp Cepl

Partner
DLA Piper

Julia Florence

Assistant General Counsel (Patents)
GlaxoSmithKline

Marjan Noor

Partner
Allen & Overy

Guido Pontremoli

Corporate IP Patent Director
Chiesi Farmaceutici

Corinna Sundermann

Senior Vice President IP Management
Fresenius Kabi Deutschland GmbH

Ms Kene Gallois

Head of Life Science
Daniel Legal & IP Strategy

Robin Ellis

Head of IP Product Development & Strategy
Sandoz

Azadeh Mehrabi

Strategic Intellectual Property Manager
Biotronik

Dr. Ulrich Storz

Senior Partner
Michalski Hüttermann & Partner Patentanwälte mbB

Rob Aerts

IP Director
Tigenix SAU

Sam Granata

Judge
Antwerp Court of Appeal

Nicolas Ruiz

Head of IP
Esteve

John D. Murnane

Partner
Fitzpatrick, Cella, Harper & Scinto

Arvid van Oorschot

Partner
Vondst Advocaten N.V.

Dr Dieter Tzschoppe

Director,Healthcare,
Biotechnology and
Chemistry
European Patent Office

Vladislav Ugryumov

Partner
Gowling WLG

Patent Litigation Trends in Russia

October 17, 2018 3:30 pm

Ha Kung Wong

Partner
Fitzpatrick, Cella, Harper & Scinto

Us vs. Them: A Biologics Wargame Exercise

October 17, 2018 1:30 pm

Scott Reed

Partner
Fitzpatrick, Cella, Harper & Scinto

Us vs. Them: A Biologics Wargame Exercise

October 17, 2018 1:30 pm

Richie Paul

Vice President, Intellectual Property Operations
Alkermes Pharma Ireland Limited

Us vs. Them: A Biologics Wargame Exercise

October 17, 2018 1:30 pm